Tags : Receives the US FDA Marketing Approval for Detection of Ebola Virus Antigens

OraSure Technologies’ Rapid Diagnostic OraQuick Ebola Rapid Antigen Test Receives

Shots: The approval is based on multiple clinical studies of blood samples and cadaveric oral fluid from the 2014 West African outbreak plus multiple analytical studies Themarketing authorization for firstrapid diagnostic test for EVD is reviewed under De Novo premarket review pathway reflecting the ongoing collaboration between the US Government and test developers to gather […]Read More